抗体市场：目标、技术、管道数据库：1 年订阅

Antibody Target, Technology & Pipeline Database: 1-Year Subscription

出版日期: 年间契约型资讯服务 | 出版商:

La Merie Publishing | 英文

价格

简介目录

作为抗体数据库，本报告提供了超过 6,231 个与抗体疗法相关的上市和研发项目的在线信息。预定义目标和技术的向下滚动菜单使选择感兴趣的项目变得容易。

内容

表格格式的项目列表

药品代码
目标
复合类
公司
字段
治疗领域
适应症
研发阶段

治疗领域

循环系统/血液
皮肤科
消化系统
泌尿科、肾科、妇科领域
传染病和毒理学
代谢和分泌
神经学/精神病学
肿瘤学
眼科/耳鼻喉科
骨科、牙科、麻醉科、外科
肺/呼吸系统
风湿病和自身免疫性疾病

默认技术向下滚动菜单 - 示例

按负载分类的抗体-药物偶联物（例如 auristatin、PBD）
双特异性抗体
寡聚/多克隆抗体
体外产生的抗体（噬菌体展示）
Fab 抗体
Fc-融合蛋白
激动剂抗体
转基因小鼠抗体
人类细胞来源的抗体

默认目标向下滚动菜单 - 示例

抗体-药物偶联物 (ADC)
2022 年抗体销售额
2022 年生物仿製药抗体销售额
生物仿製药抗体
Bio-Superior 抗体
CLDN6 抗体
2抗体
c-MET/HGF 抑製剂
CD20 抗体
DLL3 抗体
GPC3 抗体
Her2 抗体
IGF-1R 拮抗剂
免疫细胞因子
免疫毒素
白细胞介素 12/23 拮抗剂
白介素 13 拮抗剂
白介素 17 拮抗剂
间皮素抗体
PSMA 抗体
ROR1 抗体

简介目录

Product Code: LMDB0006

Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 6,231 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their

Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)

Target (e.g. Her2, CD20, PD-1/PD-L1, CLDN18)

Pipelines (selected by target, therapeutic area, company, technology)

Sales (for marketed antibodies)

R&D Phase (clinical phases, market, preclinical)

Territory (countrywise)

Therapeutic Area (e.g. infectious, oncology, gastrointestinal)

Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

Antibody-Drug Conjugates
Bispecific Antibodies
Vectorized Antibodies (in vivo expression)
Masked Antibodies
TCR-like Antibodies
T-Cell Engaging Antibodies
Natural Killer (NK) Cell Engaging Antibodies
Biosimilar and Biosuperior Antibodies
Sales Data of more than 120 therapeutic antibodies (incl. sales history)

Prerequisite: Internet access.

Purchase of the subscription provides a 1-year online access to the data of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.